Michael Finney Overview
- Investor Type
-
Angel
- Investments
-
2
- Portfolio
-
1
- Exits
-
1

Michael Finney General Information
Description
Dr. Michael Finney serves as Managing Director at Finney Capital. Dr. Finney co-founded and served as Chairman at Addition Therapeutics. He serves as Chairman at Thrive Bioscience. He also serves as the Board Member of Orion Genomics. He has been Acting as Chief Executive Officer of Vaxart Inc. since July 2009. Dr. Finney serves as Chief Scientific Officer of MJ Bioworks Inc. Dr. Finney Co-founded MJ Research, Incorporated in 1987. He founded MJ Bioworks. He has experience with founding and managing start-up companies. He served as Chief Scientific Officer of MJ Research Inc. He served as an Advisor of Vaxart Inc. He serves as Chairman & Advisor at Sage Science. He serves as Director of Vaxart, Inc. He serves as Director of Orion Genomics LLC. He serves as a Director of WaveMark Inc. He served as a Director of PharmaSecure, Inc. He served as a Scientific Advisor of Orion Genomics LLC. Dr. Finney is the author of numerous scientific articles and holds 7 US patents. Dr. Finney completed postdoctoral work at the Harvard Medical School Department of Genetics at Massachusetts General Hospital from 1987 to 1990. Dr. Finney received a BA in Biochemical Sciences from Harvard University in 1980 and a Ph.D. in Biology from the Massachusetts Institute of Technology in 1987. He was a founder and Chief Scientific Officer of MJ Research and is currently an investor in over a dozen privately-held companies in biotechnology, alternative energy, and allied areas. He is a director of the privately-held companies Vaxart, Wavemark, Innerscope Research, Sage Science, a director of the non-profit G Corp (administrator of the industry-leading AGBT Genomics meeting), and a past director of Mission Motors and Pharmasecure; he is also former Chief Executive Officer of Vaxart. Dr. Finney was a Postdoctoral Fellow at Harvard Medical School/Massachusetts General Hospital. He holds eight U.S. patents. He served as Board Member at Banyan Energy.
Business Details
Primary Investor Type
Corporate Office
- 170 Harbor Way
- Suite 300
- South San Francisco, CA 94080
- United States
Michael Finney Investments (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Intabio | 14-Sep-2017 | Seed Round | Discovery Tools (Healthcare) | Generating Revenue | ||
Thrive Bioscience | 30-Apr-2015 | Other Healthcare Technology Systems | Generating Revenue |
Michael Finney Exits (1)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Intabio | 21-Jan-2021 |
Michael Finney Investments by Industry, Year, and Region
Michael Finney FAQs
-
Who is Michael Finney?
Michael Finney is an angel Investor who has made 2 investments.
-
What kind of investor is Michael Finney?
Michael Finney is an angel investor.
-
What does Michael Finney do?
As an angel investor, Michael Finney invests personal money into promising companies, typically in exchange for equity.
-
How many board seats does Michael Finney hold?
Michael Finney holds 3 board seats including Vaxart, Orion Genomics, and seqWell.
-
What has Michael Finney invested in?
Michael Finney has made numerous investments in companies like Intabio and Thrive Bioscience within the Discovery Tools (Healthcare) and Healthcare Technology Systems industries.
-
What has Michael Finney invested in recently?
Michael Finney's latest investment was on 14-Sep-2017 in Intabio, a company within the Discovery Tools (Healthcare) industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »